Spotlight News Spot

Video:ACGT fellow, Dr. Samuel Katz,Yale Medical Center, speak about cell and gene therapies for cancer treatment.

See all ACGT videos here

July 12, 2017

STAMFORD, Conn., July 12, 2017 Today the FDAs Oncologic Drugs Advisory Committee, an independent panel of experts, voted unanimously to recommend to the FDA Read More

June 26, 2017

On Saturday, June 24, 2017, more than 300 swimmers made waves in the fight to defeat cancer at the 11th annual Swim Across America Greenwich-Stamford Read More

May 25, 2017

Dear Friends: I have always considered myself to be a very lucky person, but I wasnt feeling very lucky the day I was told I Read More

June 22, 2017

I have always considered myself to be a very lucky person, but I wasnt feeling very lucky the day I was told I had chronic Read More

June 3, 2016

In 2012, Bob Levis, an Allentown, Pennsylvania resident, believed he had come to the end of his life. Diagnosed in 2002 with chronic lymphocytic leukemia, Read More

March 16, 2014

They took my cancer cells and irradiated them, and then injected them back into my body so my immune system would kick in, Morrow said. Read More

June 21, 2017

Alliance for Cancer Gene Therapy fellow, Dr. Samuel Katz at Yale Medical Center, speaks about cell and gene therapies for cancer treatment. There has been Read More

October 5, 2016

Dr. Stephen Eck, Member of Alliance for Cancer Gene Therapys Scientific Advisory Council, talks about the importance of personalized therapies for cancer. Historically, weve tried Read More

October 5, 2016

Dr. Michael Lotze, Member of Alliance for Cancer Gene Therapys Scientific Advisory Council speaks about progress in the fight against cancerhe has witnessed during his Read More

The mission of ACGT is to seek out and support revolutionary scientific research into the causes, treatment and prevention of all types of cancer using cells and genes as medicine.

Cell and gene therapies are destroying tumors every day in the laboratory and in human trials, targeting only the cancer with few side effects to healthy tissue. ACGTs rigorous grant review process, under the guidance of a preeminent Scientific Advisory Council, have resulted in some of the most successful breakthroughs in the history of cancer treatments and led to many patients in complete remission.

100% of our funding supports innovation and translational science that is proving again and again to offer better treatment options than the traditional therapies of chemotherapy, surgery and radiation. Every donation brings us closer to saving lives and changing the way we treat cancer forever.

Video:ACGT fellow, Dr. Samuel Katz,Yale Medical Center, speak about cell and gene therapies for cancer treatment.

See all ACGT videos here

At the ACGT anniversary gala in April, Robert Vonderheide, MD, DPhil, the Hanna Wise Professor in Cancer Research and newly appointed Director of the Abramson Read More

This fourth in our blog series on the progress of cell and gene therapy for cancer focuses on a treatment that has made huge strides Read More

In our last blog, we described the progress and promise of CAR-T, an immunotherapy that has been particularly successful with leukemia and lymphoma. As a Read More

2017 All rights reserved by ACGT. ACGT is a 501(c)(3) organization and all contributions are tax-deductible under the law of your state.

Read the original:

Alliance for Cancer Gene Therapy (ACGT) Foundation